Trial intelligence / Profile preview

Parenteral Nutrition in HSCT

NCT04425642Completed

Sponsor
First Saint Petersburg State Medical University
Start
Feb 2020
Primary completion
Nov 2020
Modality
Lipid-based Nanoparticles
Countries
1
01

Overview

Randomised, open-label trial of long-chain triglyceride lipid emulsion in hematologic malignancy (3 arms), sponsored by First Saint Petersburg State Medical University. Primary endpoint: Number of patients with low tolerability of different parenteral nutrition schemes at 60 days. Started Feb 2020; status: completed.

02

Drugs

long-chain triglyceride lipid emulsion
03

Conditions

hematologic malignancy

Beyond the preview

Go deeper on NCT04425642.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04425642.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call